Chest
Volume 71, Issue 4, April 1977, Pages 558-559
Communications to the EditorTetrahydrocannabinol as a Bronchodilator: Why Bother?
REFERENCES (7)
- et al.
Effect of oral administration of delta 9-tetrahydrocannabinol on airway mechanics in normal and asthmatic subjects
Chest
(1976) - Marihuana and Health: Fifth Annual Report to the Congress from the Secretary of Health, Education, and Welfare. US...
- et al.
Medical manifestations associated with hashish
JAMA
(1971)
There are more references available in the full text version of this article.
Cited by (6)
The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig
2013, Pulmonary Pharmacology and TherapeuticsCitation Excerpt :The main psychoactive constituent of cannabis, (−)-Δ9-tetrahydrocannabinol (Δ9-THC) has been found to have bronchorelaxant activity both in healthy subjects and subjects with asthma, but does not appear to be clinically beneficial in the acute treatment of respiratory diseases [1–4].
Alternative medicine for allergy and asthma
2000, Journal of Allergy and Clinical ImmunologyTowards cannabinoid drugs
1987, Progress in Medicinal ChemistryImplications of marijuana decriminalization on the practice of pulmonary, critical care, and sleep medicine: A report of the American thoracic society marijuana workgroup
2015, Annals of the American Thoracic SocietyThe effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough
2015, Journal of Pharmacology and Experimental TherapeuticsThe endocannabinoid system as an emerging target of pharmacotherapy
2006, Pharmacological Reviews
Copyright © 1977 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.